Ocular Drug Delivery Market Updates 2024 : Rise in Prevalence of Eye Diseases is Predicted to Cross pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
StockNews.com lowered shares of Alimera Sciences (NASDAQ:ALIM – Free Report) from a buy rating to a hold rating in a report published on Tuesday morning. Separately, Maxim Group assumed coverage on Alimera Sciences in a report on Monday, March 25th. They set a buy rating and a $10.00 target price on the stock. View Our […]
StockNews.com downgraded shares of Alimera Sciences (NASDAQ:ALIM – Free Report) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning. Separately, Maxim Group started coverage on shares of Alimera Sciences in a research report on Monday, March 25th. They set a buy rating and a $10.00 price […]
StockNews.com Lowers Alimera Sciences (NASDAQ:ALIM) to Hold theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Alimera Sciences (NASDAQ:ALIM – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Monday. Separately, Maxim Group initiated coverage on shares of Alimera Sciences in a research report on Monday, March 25th. They set a “buy” rating and a $10.00 price target […]